Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hypofractionated Dose”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT05540899
What this trial is testing

Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaSquamous Cell Carcinoma of the Larynx+2 more
American College of Radiology 14
Not applicableUnknownNCT02446366
What this trial is testing

Hypofractionated Stereotactic Body Radiation Therapy for Patients With Prostate Cancer That Was Removed by Surgery

Who this might be right for
Stage II Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Adenocarcinoma
University of Southern California 24
Early research (Phase 1)Study completedNCT00214123
What this trial is testing

Hypofractionated Radiotherapy for Lung Cancer

Who this might be right for
Lung Cancer
University of Wisconsin, Madison 79
Early research (Phase 1)Study completedNCT00911118
What this trial is testing

Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer

Who this might be right for
Prostate CancerAdenocarcinoma
Memorial Sloan Kettering Cancer Center 120
Testing effectiveness (Phase 2)Study completedNCT00214097
What this trial is testing

Phase I/II Hypofractionated Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 347
Early research (Phase 1)Active Not RecruitingNCT06020885
What this trial is testing

Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.

Who this might be right for
Esophageal Squamous Cell Carcinoma
Sun Yat-sen University 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT02179086
What this trial is testing

Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
NRG Oncology 624
Testing effectiveness (Phase 2)Looking for participantsNCT07044635
What this trial is testing

Shortened Course of Radiation Therapy After Trans-oral Robotic Surgery in Patients With HPV-Mediated Oropharyngeal Squamous Cell Carcinoma.

Who this might be right for
Oropharyngeal Squamous Cell CarcinomaHPV-mediated Oropharyngeal Squamous Cell Carcinoma
University of Utah 42
Early research (Phase 1)Study completedNCT04580446
What this trial is testing

HYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer

Who this might be right for
Human Papillomavirus-Related CarcinomaOropharyngeal Cancer
University of Texas Southwestern Medical Center 24
Not applicableActive Not RecruitingNCT07605507
What this trial is testing

Hypofractionated Whole Pelvic Chemoradiotherapy With iRex Optimization in Cervical Cancer

Who this might be right for
Cervical Cancer
Siriraj Hospital 40
Testing effectiveness (Phase 2)UnknownNCT00938418
What this trial is testing

Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Stage III Non-Small Cell Lung Cancer
National University Hospital, Singapore 43
Not applicableLooking for participantsNCT07483658
What this trial is testing

Non-inferiority Study Comparing Salvage Pelvic Radiotherapy in 25 Fractions (62.5 Gy/25) Versus 20 Fractions (52.5 Gy/20) for Recurrent Prostate Cancer After Surgery.

Who this might be right for
Reccurent/Metastatic Solid Tumor DiseaseProstate Cancer (Post Prostatectomy)Prostate Cancer+3 more
CHU de Quebec-Universite Laval 434
Not applicableUnknownNCT03699969
What this trial is testing

A Study Comparing Hypofractionated Dose Escalated VMAT to Conventional CCRT in Locally Advanced Head and Neck Cancer

Who this might be right for
Locally Advanced Head and Neck Cancer
Cairo University 63
Not applicableNot Yet RecruitingNCT07823309
What this trial is testing

Quad Shot Versus Split Course Radiotherapy in Incurable Head and Neck Cancer

Who this might be right for
Head and Neck NeoplasmsSquamous Cell Carcinoma of Head and Neck
Instituto Nacional de Cancerologia, Columbia 40
Early research (Phase 1)Study completedNCT00822887
What this trial is testing

Dose Escalation Study of Vandetanib With Hypofractionated Stereotactic Radiotherapy in Recurrent Malignant Gliomas

Who this might be right for
Malignant Gliomas
University of Colorado, Denver 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT05003752
What this trial is testing

Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRadiation Toxicity
German Oncology Center, Cyprus 40
Early research (Phase 1)Study completedNCT01392209
What this trial is testing

Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma

Who this might be right for
Brain CancerMALIGNANT GLIOMAGlioblastoma+5 more
Memorial Sloan Kettering Cancer Center 15
Large-scale testing (Phase 3)Active Not RecruitingNCT01444820
What this trial is testing

Hypofractionated, Dose Escalation Radiotherapy for High Risk Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital 329
Early research (Phase 1)Study completedNCT01215500
What this trial is testing

Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer

Who this might be right for
TumorCancerMelanoma+2 more
University of Chicago 63
Not applicableLooking for participantsNCT06995664
What this trial is testing

Partial Volume High-Dose Irradiation in Renal Cell Carcinoma for Intra-TUmoural Control ALongside Current Management

Who this might be right for
Renal Cell CarcinomaRenal Cell Carcinoma Metastatic
Royal Marsden NHS Foundation Trust 24
Next Page